Sanaria Inc.
PrivateLast Round
Grant
Nov 27, 2023
Total Funding Raised
$108.13M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Sanaria Inc. operates in Healthcare & Life Sciences and is based in Rockville, Maryland. Its latest recorded funding round was a Grant round in November 2023.
Sanaria Inc. is a biotechnology company that develops and commercializes whole-parasite malaria vaccines to prevent malaria infection and transmission.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Drug Discovery
Business Model
B2G
Customer Profile
Government Contracts, Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Sanaria Inc. Comparables
Compare Sanaria Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| MalarVx, Inc. | 83% | |
| Vac4All | 78% | |
| Sumaya Biotech GmbH & Co. KG | 78% |
For institutional investors. Book with your work email.
Sanaria Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Nov 27, 2023 | ||||
| Grant | Nov 5, 2020 | ||||
| Grant | Jun 29, 2015 | ||||
| Grant | Feb 23, 2009 | ||||
| Grant | Jan 29, 2007 | ||||
Grant | Dec 14, 2006 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Sanaria Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| National Institute of Allergy and Infectious Diseases | Grant |
| Gates Foundation | Grant |
| U.S. Army Medical Research Acquisition Activity | Grant |
| Food and Drug Administration | Grant |
| EU Malaria Fund | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 20, 2026
Monthly visitors increased 34% MoM.
- Mar 2, 2026
Monthly visitors increased 37% MoM.
For institutional investors. Book with your work email.
Sanaria Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Sanaria Inc.'s valuation, stock price, and market status.
Is Sanaria Inc. a public or private company?
Sanaria Inc. is a private company.
What is the current stock price of Sanaria Inc.?
Sanaria Inc. is a private company, so its shares have no public market price. Caplight tracks Sanaria Inc.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Sanaria Inc. worth (valuation)?
Valuation information for Sanaria Inc. is not publicly available.
Can I buy Sanaria Inc. stock?
Sanaria Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Sanaria Inc.'s last funding round?
Sanaria Inc.'s most recent funding round was Grant on November 27, 2023.
Who are the main investors in Sanaria Inc.?
Key investors in Sanaria Inc. include National Institute of Allergy and Infectious Diseases, Gates Foundation, U.S. Army Medical Research Acquisition Activity, Food and Drug Administration, EU Malaria Fund.
Will Sanaria Inc. IPO soon?
No public IPO plans have been announced for Sanaria Inc..
How can I track Sanaria Inc. secondary market activity?
Caplight tracks bids, offers, and trades in Sanaria Inc.'s shares on secondary markets.